Management ChangeJul 22, 2026, 08:36 AM
Dr. Reddy's Appoints Dr. Sridevi Khambhampaty as Global Head of Biologics
AI Summary
Dr. Reddy's Laboratories has appointed Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, effective July 22, 2026. She will also join the Management Council, bringing over two decades of biopharmaceutical experience. Additionally, the company confirmed the appointment of M/s Deloitte Haskins & Sells, LLP as its Independent Registered Public Accounting Firm for SEC filings, aligning with their prior appointment as Statutory Auditors.
Key Highlights
- Dr. Sridevi Khambhampaty appointed Global Head of Biologics.
- She is also inducted as a Member of the Management Council.
- Appointment effective July 22, 2026.
- M/s Deloitte Haskins & Sells, LLP appointed Independent Registered Public Accounting Firm.
- Deloitte will audit 20-F financial statements and review 6-K interim statements.
- This aligns with their prior appointment as Statutory Auditors.
Price Impact
More from RDY